Yes, here's one:-

L-DOPA modifies the antidepressant-like effects of reboxetine and fluoxetine in rats.

Miguelez C, Berrocoso E, Mico JA, Ugedo L.

Neuropharmacology. 2013 Apr;67:349-58. doi: 10.1016/j.neuropharm.2012.11.016. Epub 2012 Dec 2.

Here there is my paper on the issue

Article Mechanisms of antidepressant action: An integrated dopaminer...

Maybe these could help you: 

1. Mesolimbic Dopamine Neurons in the Brain Reward Circuit Mediate Susceptibility to Social Defeat and Antidepressant Action. Jun-Li Cao, Herbert E. Covington III, Allyson K. Friedman, Matthew B. Wilkinson, Jessica J. Walsh, Donald C. Cooper,Eric J. Nestler and Ming-Hu Han. The Journal of Neuroscience, December 8, 2010 • 30(49):16453–16458.

2. Prospect of a Dopamine Contribution in the Next Generation of Antidepressant

Drugs: The Triple Reuptake Inhibitors. Bruno P. Guiard, Mostafa El Mansari and Pierre Blier. Current Drug Targets, 2009, 10, 1069-1084.

Regards,

Daniela.

Thank you.